2018 ATS Lung Transplant Week Webinar

Save the Date

Free Webinar: Wednesday, September 26 • 2-3pm ET

The Lung Transplant Foundation teams with the American Thoracic Society to present:

Emerging Innovations to Advance Lung Transplant Patient Outcomes

Celebrating our 10th anniversary in 2018, LTF has evolved into the only major nonprofit dedicated to supporting research into post-transplant rejection. We partner with cutting-edge companies on the forefront of emerging technologies to improve the quality of life for lung transplant population:

In this informative webinar, a panel of experts discuss some of the exciting new advances that have the potential to vastly improve the lives of lung transplant patients:

  • Improved organ preservation during transport for more viable organs for transplant
  • Less-invasive skin cancer treatment for lung transplant patients
  • FDA patient engagement initiative
Presenters:
 Skin Cancer and SRT - Jeff Goldstein Interview

Skin Cancer and SRT - Jeff Goldstein Interview

President & Founder Lung Transplant Foundation

Steven P Keller.,M.D., Ph.D.

Steven P Keller.,M.D., Ph.D.

Medical Director, ECMO
Instructor in Medicine, Harvard Medical School
Brigham and Women’s Hospital, Pulmonary and Critical Care Medicine

Dr. Keller joined the Division of Pulmonary and Critical Care Medicine in July 2016 as an Instructor and currently attends on the lung transplant, cardiac surgical and medical intensive care units, and serves as Medical Director of the ECMO mechanical support service.  He joined the Brigham and Women’s Hospital from the University of Pittsburgh Medical Center where he was on faculty and attended on the cardiothoracic, trauma, and medical intensive care units.

He received his medical degree from Stanford University and completed residency training in internal medicine at the Massachusetts General Hospital prior to completing fellowship training in pulmonary and critical care medicine at Johns Hopkins Hospital and the National Institutes of Health.  Before pursuing a career in medicine, Dr. Keller received his undergraduate degree from Purdue University in electrical engineering and his master’s in semiconductor physics at Cambridge University where he studied as a Churchill Scholar. He received his doctorate in medical engineering from the Massachusetts Institute of Technology where he was awarded the Department of Defense and National Science Foundation graduate fellowships.

Dr. Keller is affiliated faculty at the Harvard-MIT Biomedical Engineering Center where he conducts research on mechanical circulatory support, organ-device interactions, and extracorporeal organ perfusion.

Andrea C. Furia-Helms, M.P.H.

Andrea C. Furia-Helms, M.P.H.

Director, Patient Affairs Staff
Office of Medical Products and Tobacco, Office of the Commissioner
U.S. Food and Drug Administration

Andrea Furia-Helms is the Director of the Patient Affairs Staff in the Office of Medial Products and Tobacco, Office of the Commissioner. She works with the FDA medical product centers and other offices to support the FDA’s ongoing patient engagement efforts and is coordinating cross-cutting patient engagement activities to ensure patients, caregivers, and advocates have opportunities to share their perspectives in the FDA regulatory meetings.  Ms. Furia-Helms spent the over ten years in the FDA’s Office of Health and Constituent Affairs where she directed the FDA Patient Representative Program and coordinated patient engagement activities.

Prior to FDA, Ms. Furia-Helms was Director of the Back to Sleep (now Safe to Sleep) campaign, a public-private partnership to educate communities on Sudden Infant Death Syndrome (SIDS), at the National Institutes of Health.  She developed SIDS outreach initiatives for African American, American Indian and Latino communities.

Ms. Furia-Helms has a B.A. in psychology from Framingham State University, a B.S. degree in community health education from the University of Maryland, and a Master of Public Health degree from The George Washington University.

Susan Guo, MD

Susan Guo, MD

Radiation Oncologist
New Mexico Cancer Center/NMOHC

Dr. Guo is a board-certified radiation oncologist at New Mexico Cancer Center.  She received her BA in French from Columbia College and her MD from the College of Physicians and Surgeons at Columbia University. Dr. Guo completed residency in radiation oncology at the Cleveland Clinic, where she served as Chief Resident from 2011 through 2012.  She is the lead skin cancer specialist at New Mexico Cancer Center, which offers the only superficial radiotherapy unit in the state. In her spare time, she enjoys yoga and traveling.

Facts About Lung Transplant


 

One organ donor can save 8 lives and change the lives of more than 50 people. Donated lungs require special methods of preservation to keep them viable and may be preserved between 4-6 hours between the time of procurement and transplantation.

A lung transplant transforms lives affected by diseases such as cystic fibrosis, pulmonary fibrosis, Sarcoidosis, pulmonary hypertension, and COPD.

While transplants give recipients a second chance, they aren’t a cure. Rejection rates for lung transplant recipients is worse than that of any transplanted organ.

The Lung Transplant Foundation wants to change that through funding research to stop all lung transplant rejection.